Levels of 2 proteins in cerebrospinal fluid could potentially be used to identify people with Alzheimer's disease before they show clinical symptoms, according to a new study. The finding could open new opportunities for developing Alzheimer's therapies.
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (0)
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



